Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 11/20 | 0.40 |
| ▸ | PPARG | P37231 | 10/20 | 0.40 |
| ▸ | PPARD | Q03181 | 7/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7066803 | 0.95 | MAPT (0.42) | MAPTSMN1; SMN2THRBALDH1A1LMNA | |
| SCHEMBL7067676 | 0.93 | MAPT (0.40) | MAPTSMN1; SMN2THRBALDH1A1LMNA | |
| SCHEMBL7069897 | 0.93 | MAPT (0.40) | MAPTSMN1; SMN2THRBALDH1A1LMNA | |
| SCHEMBL7067412 | 0.91 | PLA2G2A (0.40) | MAPTSMN1; SMN2THRBALDH1A1LMNA | |
| SCHEMBL7067231 | 0.91 | PLA2G2A (0.40) | MAPTSMN1; SMN2THRBALDH1A1LMNA | |
| SCHEMBL7070113 | 0.90 | PPARG (0.40) | MAPTALDH1A1KDM4EPPARAPPARG | |
| SCHEMBL7066084 | 0.89 | NUDT1 (0.41) | MAPTPPARAPPARGPPARDNPSR1 | |
| SCHEMBL7072687 | 0.86 | PPARA (0.39) | MAPTSMN1; SMN2THRBPPARAPPARG | |
| SCHEMBL7070904 | 0.86 | PPARA (0.57) | PPARAPPARGPPARD | |
| SCHEMBL7067917 | 0.86 | PPARA (0.40) | MAPTSMN1; SMN2THRBALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030212100-A1 | Quinoline derivatives and medicinal use thereof | MITSUI CHEMICALS, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212100-A1 | Quinoline derivatives and medicinal use thereof | PPARG, PPARD, PPARA | MAPT 2433/4885SMN1; SMN2 3691/4885THRB 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.